Ketotifen Unit Dose Stulln

Ketotifen, the active ingredient in Ketotifen Unit Dose Stulln, is an antihistamine and mast cell stabilizer presented as a unit dose ophthalmic solution for ocular use. It is employed to relieve ocular itching, redness, swelling and improves visual comfort associated with allergic conjunctivitis and vernal keratoconjunctivitis in patients requiring topical eye therapy.

GNH USA supplies Ketotifen Unit Dose Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions through reliable logistics networks worldwide.

Ketotifen is an antihistamine/mast cell stabilizer used to manage ocular allergic conditions.

Allergic conjunctivitis: reduces itching, redness and swelling while improving comfort. Vernal keratoconjunctivitis: controls chronic inflammation and helps prevent corneal damage. Seasonal allergic eye disease: alleviates symptoms during high pollen periods.

Ketotifen may cause local ocular reactions.

Common Side Effects: - Stinging or burning sensation upon instillation. - Transient blurred vision. - Mild eye irritation or redness. - Temporary foreign‑body sensation.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema). - Corneal ulceration or persistent eye pain. - Significant vision loss requiring immediate medical attention.

Ketotifen should be used with caution in specific situations.

Avoid use in patients with known hypersensitivity: discontinue if severe reaction occurs. Do not use if ocular infection is present: treat infection before initiating therapy. Consult physician before combining with other ophthalmic medications: assess compatibility. Use with caution in glaucoma patients: monitor intraocular pressure regularly. Store at room temperature: keep in the original container, protect from light and moisture.

Ketotifen may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent use with topical ophthalmic anesthetics: may increase corneal toxicity. - Combination with other mast cell stabilizers: risk of additive ocular irritation. - Use with systemic antihistamines: may enhance sedation, although ocular exposure is minimal.

Moderate Interactions (Monitor Closely): - Co‑administration with prostaglandin analog eye drops: monitor for increased inflammation. - Use with preservative‑containing contact lens solutions: may increase irritation.